These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5577492)

  • 21. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 22. 3(2H)-isoquinolones. 1. 3-Oxygenated analogs of papaverine as peripheral vasodilators.
    Kreighbaum WE; Kavanaugh WF; Comer WT; Deitchman D
    J Med Chem; 1972 Nov; 15(11):1131-5. PubMed ID: 4654663
    [No Abstract]   [Full Text] [Related]  

  • 23. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
    Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
    J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular activity of some substituted 2-aminobenzoquinolizines.
    Van Dyke JW; Havera HJ; Johnson RD; Vidrio H; Viveros A
    J Med Chem; 1972 Jan; 15(1):91-4. PubMed ID: 5007102
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in the calculated myocardial oxygen consumption during adenosine infusion versus estimates of developed tension and velocity of contraction.
    Lammerant J; Becsei I; Mertens-Strijthagen J; De Schryver C
    Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):166-78. PubMed ID: 5473172
    [No Abstract]   [Full Text] [Related]  

  • 27. Coronary pressure-blood flow relations. The effect of norepinephrine.
    Brandfonbrener M; Gracey D; Nice R
    Am J Cardiol; 1969 Mar; 23(3):417-23. PubMed ID: 5777689
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 29. A new generation of coronary vasodilators in stress perfusion imaging.
    Iskandrian AE
    Am J Cardiol; 2007 Jun; 99(11):1619-20. PubMed ID: 17531594
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography.
    Bin JP; Le DE; Jayaweera AR; Coggins MP; Wei K; Kaul S
    J Am Soc Echocardiogr; 2003 Aug; 16(8):871-9. PubMed ID: 12878997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intracoronary CO 2 gas injection on myocardial blood flow.
    Liu SM; Alexander CS
    Cardiovasc Res; 1972 Sep; 6(5):478-81. PubMed ID: 5076274
    [No Abstract]   [Full Text] [Related]  

  • 32. Direct and reflex effects of nitroglycerin on coronary and left ventricular dynamics in conscious dogs.
    Vatner SF; Higgins CB; Milland RW; Franklin D
    J Clin Invest; 1972 Nov; 51(11):2872-82. PubMed ID: 4404139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O; Grossmann W; Stühlinger W; Raberger G
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of inhibition of lipolysis on heart failure following acute coronary occlusion in the dog.
    Kjekshus JK
    Cardiovasc Res; 1974 Jan; 8(1):73-80. PubMed ID: 4819492
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1972 Dec; 46(4):585-93. PubMed ID: 4655263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular actions of substituted adenosine analogues.
    Angus JA; Cobbin LB; Einstein R; Maguire MH
    Br J Pharmacol; 1971 Apr; 41(4):592-9. PubMed ID: 5579459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potentiating effect of methyl hesperidin on coronary vasodilation induced by adenosine or related compounds.
    Tsunoo M; Kawazoe K; Iwata Y; Kimura F
    Arzneimittelforschung; 1967 Aug; 17(8):979-80. PubMed ID: 5632073
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct and systemic effects of hexobendine on renal function.
    Cho YW; Pearson JE; Saito S
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):402-14. PubMed ID: 4694374
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of nitric oxide in vascular tone and in reactivity to isoproterenol and adenosine in the goat coronary circulation.
    Fernández N; Sánchez MA; Martínez MA; García-Villalón AL; Monge L; Gómez B; Diéguez G
    Eur J Pharmacol; 2000 Jan; 387(1):93-9. PubMed ID: 10633166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.